This is a preprint.
Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold
- PMID: 32511451
- PMCID: PMC7239079
- DOI: 10.1101/2020.04.27.20081893
Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold
Update in
-
Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold.J Theor Biol. 2022 May 7;540:111063. doi: 10.1016/j.jtbi.2022.111063. Epub 2022 Feb 18. J Theor Biol. 2022. PMID: 35189135 Free PMC article.
Abstract
Individual variation in susceptibility and exposure is subject to selection by natural infection, accelerating the acquisition of immunity, and reducing herd immunity thresholds and epidemic final sizes. This is a manifestation of a wider population phenomenon known as "frailty variation". Despite theoretical understanding, public health policies continue to be guided by mathematical models that leave out considerable variation and as a result inflate projected disease burdens and overestimate the impact of interventions. Here we focus on trajectories of the coronavirus disease (COVID-19) pandemic in England and Scotland until November 2021. We fit models to series of daily deaths and infer relevant epidemiological parameters, including coefficients of variation and effects of non-pharmaceutical interventions which we find in agreement with independent empirical estimates based on contact surveys. Our estimates are robust to whether the analysed data series encompass one or two pandemic waves and enable projections compatible with subsequent dynamics. We conclude that vaccination programmes may have contributed modestly to the acquisition of herd immunity in populations with high levels of pre-existing naturally acquired immunity, while being critical to protect vulnerable individuals from severe outcomes as the virus becomes endemic.
Keywords: COVID-19; Epidemic model; Frailty variation; Herd immunity threshold; Individual variation; Selection within cohorts.
Figures
















References
-
- Aalen O. O. (1988) Heterogeneity in survival analysis. Stat. Med., 7, 1121–1137. - PubMed
-
- Adam D. C., Wu P., Wong J. Y., Lau E. H. Y., Tsang T. K., Cauchemez S., et al. (2020) Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong. Nat. Med., 26, 1714–1719. - PubMed
-
- Aguas R., Corder R. M., King J. G., Gonçalves G., Ferreira M. U. and Gomes M. G. M. (2020) Herd immunity thresholds for SARS-CoV-2 estimated from unfolding epidemics. Preprint medRxiv, 10.1101/2020.07.23.20160762. - DOI
-
- Althaus C. L., Baggio S., Reichmuth M. L., Hodcroft E. B., Riou J., Neher R. A., et al. (2021) A tale of two variants: Spread of SARS-CoV-2 variants Alpha in Geneva, Switzerland, and Beta in South Africa. Preprint medRxiv, 10.1101/2021.06.10.21258468. - DOI
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous